Who Paid My Doc
Spectra Optia
Device Therapeutic apheresis and cell collection
PDI 05020583101203
General payments
$207,606
Research payments
$3,000
Through program year 2024, $207,606 in general payments and $3,000 in research payments were reported against Spectra Optia (Therapeutic apheresis and cell collection).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $12,463 | 5 |
| 2023 | General | $64,562 | 49 |
| 2023 | Research | $3,000 | 1 |
| 2022 | General | $60,357 | 64 |
| 2021 | General | $70,224 | 27 |
Breakdown
Each share is of general payments naming this product in 2024.
Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2024 where a state was reported.
Records
145 general · 1 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.